30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Garo Armen

Track

Insider profile

Currently holds positions in Protagenic Therapeutics Inc and Agenus Inc

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 34% 8.2% 15.1%
Success rate 80% 68% 82%
Transactions
5 80% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -79%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chairman of the Board Protagenic Therapeutics Inc Feb. 12, 2016 -
Chairman of the Board, Chief Executive Officer, Co-Founder Agenus Inc Jan. 1, 1994 -
Garo Armen's trades of Agenus Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-15 2024-02-15
US Agenus Inc (AGEN)
B Purchase
86,180 -41.7%
24.25
US$4,896,087 		86,180 -41.7% 24.25 US$4,896,087
2023-05-05 2023-05-05
S Sale
37,884 -13.0%
375.30
US$2,810,306 		37,884 -13.0% 375.30 US$2,810,306
2023-05-04 2023-05-02
B Purchase
3,234 -15.2%
46.46
US$3,088,097 		3,234 -15.2% 46.46 US$3,088,097
2021-09-14 2021-09-13
US Agenus Inc (AGEN)
S Sale
82,107 -9.6%
6.50
US$533,696 		82,107 -9.6% 6.50 US$533,696
2004-10-28 2004-10-27
US Agenus Inc (AGEN)
B Purchase
25,000 +0.2%
6.39
US$159,760 		25,000 +0.2% 6.39 US$159,760
2004-10-21 2004-10-21
US Agenus Inc (AGEN)
B Purchase
100,000 +0.9%
4.74
US$474,300 		100,000 +0.9% 4.74 US$474,300